Jim Weterings

Jimmy Weterings is currently the Vice President Research RNA Therapeutics & Delivery at Sirnaomics, where Jimmy leads the development of RNAi based therapeutics and their delivery platforms. Jimmy has a background in organic chemistry, with a PhD in Bio-Organic Chemistry from Leiden University. Jimmy has held positions at various companies, focusing on targeted delivery of oligonucleotide therapeutics in oncology and respiratory settings. Jimmy has also been a part of scientific advisory boards and presented at major international conferences within the biotechnology industry.